{
  "actions": [
    {
      "acted_at": "2019-07-31", 
      "action_code": "10000", 
      "references": [], 
      "text": "Introduced in Senate", 
      "type": "action"
    }, 
    {
      "acted_at": "2019-07-31", 
      "action_code": "", 
      "committees": [
        "SSHR"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s2387-116", 
  "bill_type": "s", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Health, Education, Labor, and Pensions", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "116", 
  "cosponsors": [
    {
      "bioguide_id": "S001217", 
      "district": null, 
      "name": "Scott, Rick", 
      "original_cosponsor": true, 
      "sponsored_at": "2019-07-31", 
      "state": "FL", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2019-07-31", 
  "number": "2387", 
  "official_title": "A bill to establish a process by which reasonable drug prices may be determined, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "We PAID Act", 
  "sponsor": {
    "bioguide_id": "V000128", 
    "district": null, 
    "name": "Van Hollen, Chris", 
    "state": "MD", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2019-07-31", 
  "subjects": [
    "Business ethics", 
    "Business records", 
    "Civil actions and liability", 
    "Competition and antitrust", 
    "Congressional oversight", 
    "Government ethics and transparency, public corruption", 
    "Government information and archives", 
    "Government studies and investigations", 
    "Health", 
    "Health care costs and insurance", 
    "Health programs administration and funding", 
    "Health technology, devices, supplies", 
    "Inflation and prices", 
    "Intellectual property", 
    "Licensing and registrations", 
    "Medical research", 
    "Prescription drugs", 
    "Public contracts and procurement", 
    "Research administration and funding", 
    "Research and development", 
    "Retail and wholesale trades", 
    "Tax-exempt organizations"
  ], 
  "subjects_top_term": "Health", 
  "summary": null, 
  "titles": [
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "We PAID Act", 
      "type": "display"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to establish a process by which reasonable drug prices may be determined, and for other purposes.", 
      "type": "official"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "We PAID Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "We Protect American Investment in Drugs Act", 
      "type": "short"
    }
  ], 
  "updated_at": "2020-12-28T22:01:24Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/s/BILLSTATUS-116s2387.xml"
}